Boston Scientific develops minimally invasive medical technologies used across a range of medical specialties, including cardiovascular interventions, rhythm management, neurology, endoscopy, urology and pelvic health. Founded in 1979, the company employs more than 53,000 people worldwide and invested approximately $1.68 billion in research and development in its most recent year. Its work spans medical device R&D, from concept through to technologies used in clinical practice.
The company's reach is substantial. Its technologies are used to treat more than 44 million patients a year, and it operates across 127 countries. Product lines include minimally invasive technologies for cardiovascular interventions, devices addressing heart rhythm management and neurological conditions, endoscopic technologies and solutions, and technologies for urology and pelvic health treatments. Engineering and technical work is therefore carried out across several distinct clinical domains rather than a single product area.
Boston Scientific states its mission as to “advance science for life”. Its stated values include caring deeply about patients and colleagues, pursuing meaningful innovation, maintaining high performance standards, global collaboration across teams, embracing diversity as a strength, and close collaboration with healthcare professionals to understand their needs.
